Breast Cancer Mortality: The National Average Is Lying to You

Breast cancer mortality in the United States has a reputation problem. On paper, it looks like a success story - deaths dropped by 26% between 2000 and 2019, sliding from 33.6 to 24.8 per 100,000 women. Headlines love that number. Politicians quote it. And if you're a white woman living in a wealthy Northeastern suburb, it probably reflects your reality pretty well. But averages are sneaky little liars, and a massive new county-level analysis just ripped the mask off this one.

The Zoom-In Nobody Asked For (But Everyone Needed)

A team of 23 researchers, led by Jinani Jayasekera and published in the Journal of the National Cancer Institute, did something deceptively simple: they stopped looking at the national scoreboard and started checking individual neighborhoods (Jayasekera et al., 2026). Using validated small-area estimation models across all U.S. counties from 2000 to 2019, they broke down breast cancer mortality by age, race, and ethnicity - and corrected for the well-documented problem of race being misreported on death certificates.

What they found should make anyone quoting that 26% decline a little uncomfortable.

Some Counties Went Backwards. Yes, Backwards.

While the nation was collectively patting itself on the back, 243 counties saw breast cancer mortality increase among Latina women under 50. Among American Indian and Alaska Native (AIAN) women aged 50 to 74, mortality rose in 108 counties. And in the 75-and-older bracket? AIAN women saw increases across 184 of 474 counties, with some jumping by as much as 124 deaths per 100,000. That's not a statistical blip - that's a five-alarm fire hidden inside a feel-good average.

Asian women aged 75 and up didn't fare much better: 589 out of 667 counties showed increases, with a median bump of 14.1 per 100,000.

Why Your Zip Code Might Matter More Than Your Oncologist

These numbers don't exist in a vacuum. Previous research from the same group at the University of Washington and NIH has shown that county-level health disparities in the U.S. are enormous and widening (Dwyer-Lindgren et al., 2022). Life expectancy can swing by decades depending on which county you happen to live in and what race you happen to be.

For AIAN women specifically, the structural barriers read like a greatest-hits album of healthcare failure: the lowest mammography screening rates of any racial group (just 31% of women 40 and older screened in the past year), chronic underfunding of the Indian Health Service, workforce shortages in rural and tribal areas, and late-stage diagnoses that trail every other demographic (Breast Cancer Research Foundation, 2024). A CDC analysis found that while overall breast cancer mortality fell by 1.6% per year among white women from 1999 to 2020, the decline for AIAN women was a paltry 0.8% (Ellington et al., 2023).

The "But We're Making Progress" Trap

Here's where the skeptic in me starts twitching. National trend data has a way of making everyone feel like the system is working. Black women still have a 38% higher breast cancer mortality rate than white women despite lower incidence - a gap that has persisted for decades (American Cancer Society, 2024). And this new study shows that for several minority populations, certain counties aren't just failing to keep pace with the national decline - they're actively losing ground.

The authors used some of the most rigorous methodology available, including corrections for racial misclassification on death certificates (a known problem that tends to undercount deaths among AIAN and Latino populations). This isn't sloppy data making things look worse than they are. If anything, previous analyses without these corrections were making things look better than they were.

So What Do We Actually Do With This?

This paper doesn't prescribe solutions, and I respect that restraint. But the implications are hard to miss: national breast cancer mortality statistics are masking local crises. Targeted interventions need to be, well, targeted - by county, by age group, by racial and ethnic population. The one-size-fits-all public health victory lap isn't just premature; for some communities, it was never accurate.

The next time someone tells you breast cancer mortality is declining in America, the correct response is: "For whom? And where?" Because this study makes clear that the answer depends entirely on who and where you are.

References

1. Jayasekera J, Hooshmand S, Strassle PD, et al. Breast cancer mortality by age and race and/or ethnicity across counties in the United States, 2000-2019. Journal of the National Cancer Institute. 2026. DOI: 10.1093/jnci/djag103. PMID: 41934099.

2. Ellington TD, Henley SJ, Wilson RJ, et al. Trends in breast cancer mortality by race/ethnicity, age, and US census region, United States, 1999-2020. Cancer. 2023;129(1):32-38. DOI: 10.1002/cncr.34503. PMID: 36309838. PMCID: PMC10128100.

3. Dwyer-Lindgren L, Kendrick P, Kelly YO, et al. Life expectancy by county, race, and ethnicity in the USA, 2000-19: a systematic analysis of health disparities. The Lancet. 2022;400(10345):25-38. DOI: 10.1016/S0140-6736(22)00876-5. PMID: 35717994. PMCID: PMC9256789.

4. American Cancer Society. Breast Cancer Facts & Figures 2024-2025. Available online.

5. Breast Cancer Research Foundation. Breast Cancer in Native American Women. 2024. Available online.

Disclaimer: The image accompanying this article is for illustrative purposes only and does not depict actual experimental results, data, or biological mechanisms.